Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.

Schuebel KE, Chen W, Cope L, Glöckner SC, Suzuki H, Yi JM, Chan TA, Van Neste L, Van Criekinge W, van den Bosch S, van Engeland M, Ting AH, Jair K, Yu W, Toyota M, Imai K, Ahuja N, Herman JG, Baylin SB.

PLoS Genet. 2007 Sep;3(9):1709-23.

2.
3.

Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.

Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF.

Clin Cancer Res. 2003 Dec 15;9(17):6389-94.

5.

The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.

Karpinski P, Ramsey D, Grzebieniak Z, Sasiadek MM, Blin N.

Mol Cancer Res. 2008 Apr;6(4):585-91. doi: 10.1158/1541-7786.MCR-07-2158.

6.

Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis.

Chan TA, Glockner S, Yi JM, Chen W, Van Neste L, Cope L, Herman JG, Velculescu V, Schuebel KE, Ahuja N, Baylin SB.

PLoS Med. 2008 May 27;5(5):e114. doi: 10.1371/journal.pmed.0050114.

7.

DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.

Foltz G, Yoon JG, Lee H, Ryken TC, Sibenaller Z, Ehrich M, Hood L, Madan A.

Oncogene. 2009 Jul 23;28(29):2667-77. doi: 10.1038/onc.2009.122.

PMID:
19465937
8.
9.

Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.

Potapova A, Hoffman AM, Godwin AK, Al-Saleem T, Cairns P.

Cancer Res. 2008 Feb 15;68(4):998-1002. doi: 10.1158/0008-5472.CAN-07-2418.

11.

Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues.

Choi JS, Kim KH, Jeon YK, Kim SH, Jang SG, Ku JL, Park JG.

Int J Cancer. 2009 Mar 15;124(6):1258-62. doi: 10.1002/ijc.24023.

12.

Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T.

Cancer Res. 2008 Jun 1;68(11):4123-32. doi: 10.1158/0008-5472.CAN-08-0325.

13.

NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.

Liu M, Peng Y, Wang X, Guo Q, Shen S, Li G.

BMC Cancer. 2010 Apr 27;10:160. doi: 10.1186/1471-2407-10-160.

14.

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y.

Cancer Res. 2003 Jul 15;63(14):4174-80.

15.

Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines.

Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, Kim IJ, Shin JH, Han IO, Park JG.

Oncogene. 2004 Sep 2;23(40):6736-42.

PMID:
15273736
16.
17.

DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines.

Suh ER, Ha CS, Rankin EB, Toyota M, Traber PG.

J Biol Chem. 2002 Sep 27;277(39):35795-800.

18.

DNA methylation biomarker candidates for early detection of colon cancer.

Yi JM, Dhir M, Guzzetta AA, Iacobuzio-Donahue CA, Heo K, Yang KM, Suzuki H, Toyota M, Kim HM, Ahuja N.

Tumour Biol. 2012 Apr;33(2):363-72. doi: 10.1007/s13277-011-0302-2.

19.

Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer.

Miotto E, Sabbioni S, Veronese A, Calin GA, Gullini S, Liboni A, Gramantieri L, Bolondi L, Ferrazzi E, Gafà R, Lanza G, Negrini M.

Cancer Res. 2004 Nov 15;64(22):8156-9.

20.

Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.

Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, Shi DR, Wang P, Yang ZH, Zhu JD.

World J Gastroenterol. 2004 Dec 1;10(23):3441-54.

Items per page

Supplemental Content

Support Center